Tan Min, Li Wenge, Zou Guming, Zhang Cong, Fang Jing
Center of Nephrology, China-Japan Friendship Hospital, Health Ministry of China, Beijing, China.
Am J Nephrol. 2016;43(5):341-7. doi: 10.1159/000445759. Epub 2016 May 11.
The significance of segmental glomerular necrosis (SGN) was not evident in immunoglobulin A nephropathy (IgAN) patients. Especially, there were a number of patients who presented with slight histopathological damage except SGN. We, therefore, conducted a study to highlight the occurrence of these cases and to define their clinical characteristics and outcomes at our centre.
The clinical, laboratory and pathological manifestations and outcomes of these IgAN patients were collected and compared with IgAN patients with simily histopathological background but without SGN. Survival curves were constructed according to the Kaplan-Meier method. Multivariate Cox regression analysis was used to identify independent factors for the development of endpoint.
Eighty-two patients with SGN but without crescents were found in Haas grades I-III. Macroscopic hematuria and prodromal infection were more popular and the mean daily proteinuria was significantly higher in patients with SGN. More patients had high serum IgA in the ecrotizing IgAN group. At last follow-up, there were no differences in hypertension, proteinuria, serum creatinine, estimated GFR and the incidence of end-point events between 2 groups. SGN was not an independent predictor for the prognosis of IgAN. Corticosteroid treatment could decrease proteinuria significantly. The outcomes of the 2 populations of necrotizing IgAN patients with or without corticosteroid treatment were not different.
SGN can be found in mild pathological damage patients and is not always associated with crescent formation. Heavier proteinuria was found in these IgAN patients. SGN was not an independent predictor for the prognosis of IgAN.
节段性肾小球坏死(SGN)在免疫球蛋白A肾病(IgAN)患者中的意义尚不明确。尤其是,有许多患者除SGN外仅表现出轻微的组织病理学损伤。因此,我们开展了一项研究,以突出这些病例的发生情况,并确定其在我们中心的临床特征和预后。
收集这些IgAN患者的临床、实验室和病理表现及预后情况,并与具有相似组织病理学背景但无SGN的IgAN患者进行比较。根据Kaplan-Meier法构建生存曲线。采用多变量Cox回归分析确定终点事件发生的独立因素。
在Haas分级I-III的患者中发现82例有SGN但无新月体形成。肉眼血尿和前驱感染更为常见,SGN患者的平均每日蛋白尿显著更高。在坏死性IgAN组中,更多患者血清IgA水平升高。在最后一次随访时,两组之间在高血压、蛋白尿、血清肌酐、估计肾小球滤过率和终点事件发生率方面没有差异。SGN不是IgAN预后的独立预测因素。皮质类固醇治疗可显著降低蛋白尿。接受或未接受皮质类固醇治疗的两组坏死性IgAN患者的预后没有差异。
SGN可见于病理损伤较轻的患者,且并不总是与新月体形成相关。这些IgAN患者存在更严重的蛋白尿。SGN不是IgAN预后的独立预测因素。